Ufonia key facts
as of Oct 2026- Developer of an AI-driven voice technology designed to replace routine patient healthcare interactions with automated phone calls.
- Ufonia is valued at approximately $17.7M as of Oct 2026 (last reported valuation).
- It has raised $4.4M.
- Notable investors include Innovate UK, Octopus Ventures, Charles Songhurst, Mark Evans, Science & Technology Facilities Council — 17 tracked in total.
- Status: Privately Held (backing).
Ufonia's last reported valuation, Sep 2022. Nothing priced has surfaced since.
- ·The complete investor list: 17 names
- ·Watch Ufonia: the Monday email on marks, rounds and moves
Ufonia funding rounds
No funding rounds for Ufonia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Ufonia
17+Ufonia valuation
Ufonia's last reported valuation was $17.7 million in Sep 2022. No priced round, secondary trade or fund mark has surfaced since.
Ufonia investors
17 investors are on record for Ufonia, including Innovate UK, Octopus Ventures, Charles Songhurst and Mark Evans.
About Ufonia
Developer of an AI-driven voice technology designed to replace routine patient healthcare interactions with automated phone calls. The company's technology offers autonomous, automated, telephone-based clinical follow-up for capturing patient-reported outcome measures, enabling healthcare organizations to monitor health and wellness through a conversational voice bot.
- Sector
- Information Technology
- HQ
- Oxford, United Kingdom
- Founded
- 2017
- Employees
- 40
- Website
- ufonia.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.